Letter to House Energy and Commerce Committee on lowering the cost of prescription drugs

PAN entirely supports the Committee’s goal of improving access to and affordability of prescription drugs.

For many in the Medicare population—which includes 54 million older adults and 9 million people living with disabilities—healthcare costs are a source of major financial strain.

The absence of an annual or monthly cap on what patients pay out of pocket directly contributes to their economic insecurity. High costs also have implications for overall patient health. High out-of-pocket costs contribute to prescription abandonment at the pharmacy counter, which ultimately negatively impacts health outcomes.